A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we describe in detail methods for extracting macrophages from the bone marrow, spleen, and infarcted heart, and subsequently assessing metabolic flux in live cells.

Abstract

Metabolic reprogramming is a hallmark of monocyte/macrophage activation and polarization between pro- and anti-inflammatory states. For example, pro-inflammatory (i.e., M1-like) monocytes/macrophages display more reliance on anaerobic glycolysis and less reliance on mitochondrial oxidative phosphorylation, whereas anti-inflammatory (M2-like) macrophages display more reliance on glucose and fatty acid oxidation in the mitochondria. Here, we describe in-depth protocols for extracting macrophages from the two major monocyte/macrophage reservoirs in the body, the spleen and bone marrow, as well as injured tissues such as the heart following myocardial infarction.

Macrophages or monocytes are extracted by immunomagnetic sorting by using antibody-tagged microbeads, which easily bind to cells without compromising their phenotypes. The extracted cells are then cultured in 96-well plates, followed by extracellular flux analysis using a metabolic flux analyzer. Both glycolysis and mitochondrial oxidative phosphorylation can be measured simultaneously in small numbers of cells (as little as 2-3 × 105 cells). This method can easily be performed in 1 day and produces reliable and repeatable results. Ultimately, these methods help to enhance our understanding of metabolic changes during immune and inflammatory responses to injury and disease, which could lead to the development of novel therapeutic targets for immunometabolic pathways.

Introduction

Immunometabolism is a blossoming field that studies the role of metabolic reprogramming in immune cells across different pathological disease and injury states. Macrophages are a key part of the innate immune system that play critical roles in inflammation, response to infection, antigen presentation, and wound healing1. Understanding how macrophages polarize between pro- and anti-inflammatory (M1-like and M2-like) subsets across different disease states is an area of ongoing and intense investigation. Recent studies have identified metabolic reprogramming as a key mechanism underlying macrophage polarization. The current paradigm is that, broadly speaking, M1-like macrophages (which are typically monocyte-like) rely more on glycolysis to fuel pro-inflammatory functions, while M2-like macrophages rely more on mitochondrial oxidative phosphorylation to quell pro-inflammatory functions and fuel anti-inflammatory processes2. Understanding how macrophage metabolism is altered in different disease states can provide insight into potential therapies that could be used to target metabolic pathways.

As an example, our lab has extensively investigated the role of macrophage metabolic reprogramming during myocardial infarction (MI)3,4,5. Macrophages play a key role in the inflammatory and wound healing response during MI and, as such, undergo polarization from M1-like towards M2-like phenotypes as the infarcted heart undergoes remodeling to form replacement scar tissue. Using the methods described herein, we have demonstrated that this polarization is characterized by unique changes in glucose and glutamine metabolism, and mitochondrial function. We describe methods for extracting cardiac macrophages, as well as splenic macrophages and bone marrow monocytes, which can be combined with extracellular flux analysis to assess ex vivo metabolic flux in a single day. We hope the methods described offer a standardized approach for assessing immune cell metabolic phenotypes to enhance reproducibility across labs studying this important topic.

Protocol

The methods below describe protocols for extracting macrophages and performing ex vivo analysis of metabolic flux from the infarcted heart following MI, the spleen, and the bone marrow (Figure 1). For the MI heart and spleen, the extraction method used is identical. All protocols involving mice were approved by the University of Mississippi Medical Center Institutional Animal Care and Use Committee (Protocol #1371, Mouton).

1. Extraction of macrophages from the infarcted heart and spleen

NOTE: Extraction of tissue macrophages uses a negative selection strategy to first remove neutrophils, which are labeled with Ly6G-microbeads, and then a positive selection strategy to obtain macrophages with CD11b-microbeads3,4,5,6. When performing this protocol, work quickly and keep the cells cold.

  1. Euthanize the mouse in accordance with AALAC and institutional guidelines by isoflurane overdose followed by removal of the heart.
  2. Remove the heart and spleen quickly and weigh the tissues.
  3. Prior to the assay, prepare PEB buffer by dissolving EDTA (2 mM) and 0.5% bovine serum albumin (w/v) in phosphate-buffered saline (PBS). Keep cold.
  4. Place the heart in cold Hank's balanced salt solution (HBSS). Mince with a sterile scalpel into small pieces.
  5. Prepare a digestion solution containing 600 U/mL collagenase type II and 60 U/mL DNase type I. Mix the tissue in 10 mL of the digestion solution in a MACS cell dissociation tube.
    NOTE: Make enough of the digestion solution to use 10 mL for each tissue (room temperature).
  6. Incubate the tissues using the cell dissociator according to the manufacturer's protocol. This will incubate the minced tissue at 37 °C with gentle spinning for ~1 h to generate a cell suspension.
  7. Move the suspension to 15 mL conical tubes and centrifuge at 300 × g for 10 min at 4 °C.
  8. Resuspend the pellet in 1 mL of PEB buffer. To generate a single-cell suspension, apply the suspension over a 30 µm filter.
  9. To lyse red blood cells, add 10 mL of 1x red blood cell lysis solution. Incubate for 5-10 min in the dark at 4 °C.
  10. Centrifuge the suspension for 300 × g for 10 min at 4 °C.
  11. Resuspend the pellet in 1 mL of PEB and count the cells using a hemacytometer.
  12. Centrifuge the suspension at 300 × g for 10 min at 4 °C.
  13. To remove neutrophils, prepare microbeads by mixing 90 µL of PEB buffer with 10 µL of anti-Ly6G microbeads per 107 cells. Mix the cell pellet with the microbead suspension and incubate for 10 min in the dark at 4 °C.
  14. To wash out unbound microbeads, add 10 mL of PEB buffer and centrifuge at 300 × g for 10 min at 4 °C.
  15. Prepare magnetic columns (MS or LS) on a magnetic stand. Wet the columns by adding 0.5-1.0 mL of PEB buffer.
    NOTE: For tissues with an abundance of immune cells (i.e., spleen), the magnetic column can easily become clogged and stop flowing. Thus, we recommend using LS columns for spleen.
  16. Resuspend the cell pellet in 500 µL of PEB buffer. Add the cell suspension to the magnetic column and let the unlabeled cells (i.e., non-neutrophils) run through. Wash the column 2x with 500 µL of PEB buffer. Collect the unlabeled cells (i.e., macrophages and other cells) in a 15 mL conical tube.
  17. Centrifuge the suspension at 300 × g for 10 min at 4 °C.
  18. Prepare microbeads by mixing 90 µL of PEB buffer with 10 µL of anti-CD11b microbeads per 107 cells. Mix the cell pellet with the microbead suspension and incubate for 15 min in the dark at 4 °C.
  19. Repeat steps 1.13-1.15.
  20. The labeled macrophages will be bound to the magnetic column. To collect them, detach the magnetic column from the magnetic stand and place it over a new 15 mL conical tube.
  21. Add 1 mL of RPMI media supplemented with 0.1% fetal bovine serum (FBS) to the column. Use the plunger to extract the macrophages into the tube. Count the macrophages using a hemacytometer.
    NOTE: The macrophages are now in the tube and ready to use for further assays.

2. Extraction of monocytes from bone marrow

NOTE: Extraction of monocytes from the bone marrow uses a negative selection strategy in which non-monocytes, including lymphocytes, natural killer cells, dendritic cells, erythroid cells, and granulocytes (i.e., neutrophils), are immunomagnetically labeled and removed.

  1. Euthanize the mouse in accordance with AALAC and institutional guidelines by isoflurane overdose followed by removal of the heart.
  2. Remove the legs from the mouse. In cold HBSS, dissect the muscle away from the tibia and femur until the bones are clean.
  3. Carefully cut off both ends of the bone. Using a 10 mL syringe with a 27 G needle, flush out the bone marrow into a 15 mL conical tube with PEB buffer. Centrifuge the suspension at 300 × g for 10 min at 4 °C.
  4. Perform steps 1.8-1.12.
  5. Add 175 µL of PEB buffer, 25 µL of FcR blocking reagent, and 50 µL of monocyte biotin-antibody cocktail per 5 × 107 of total cells. Incubate for 5 min in the dark at 4 °C.
  6. Wash by adding 10 mL of PEB buffer and centrifuge for at 300 × g for 10 min at 4 °C.
  7. Collect the pellet and re-suspend the cells in 500 µL of PEB buffer and 100 µL of anti-Biotin microbeads. Incubate for 10 min in the dark at 4 °C.
  8. Prepare magnetic columns (LS) on a magnetic stand. Wet the columns by adding 1.0 mL of PEB buffer.
  9. Immediately apply the cell suspension to the column. Use a 15 mL tube to collect the flowthrough, which contains the monocytes. The non-monocytes are bound to the magnetic column.
  10. Wash the column 2x with 1 mL of PEB buffer. Count the monocytes using a hemacytometer.
  11. To prepare the monocytes for the next step, centrifuge at 300 × g for 10 min at 4 °C. For flux analysis, resuspend the cell pellet in 1 mL of RPMI + 0.1% FBS. For flow cytometry, keep the cells in cold PEB and proceed with staining.

3. Preparation of cells for metabolic flux analysis

  1. Hydrate the sensor cartridge (the day before the assay)
    1. Remove the sensor cartridge from its package. Remove the sensor plate (green) from the wells and pipette 200 µL of calibrant fluid into each well. Place the sensor plate back on the top of the cartridge plate so that the sensors are submerged in the calibrant fluid.
    2. Place the cartridge into a non-CO2 humidified incubator (37 °C) overnight.
  2. Plating the cells
    1. Plate the cells in a 96-well culture plate in 200 µL of media for at least 1 h. Leave at least one well blank for background measurements (use the same volume of media for blank wells).
      NOTE: The optimal cell number should be determined prior to experimentation. See "Troubleshooting Tips" in the discussion for more details.
    2. When ready to perform the assay, prepare the metabolic flux media (i.e., basal RPMI or DMEM with no glucose, glutamine, pyruvate, etc). For the glycolysis stress test, ensure the basal media is supplemented with 2 mM glutamine. For the mitochondrial stress test, ensure the basal media is supplemented with 2 mM glutamine, 10 mM glucose, and 1 mM pyruvate.
    3. Carefully replace the old media with new basal media by slowly pipetting (be careful not to dislodge any cells). Check the cells under a microscope to make sure they are still present.
    4. Place the cell plate in a non-CO2 humidified incubator (37 °C).
  3. Loading the flux plate
    1. Retrieve the hydrated sensor cartridge/flux plate from the incubator.
    2. Prepare the test compounds for either glycolysis or mitochondrial stress test.
      1. Glycolysis: Using glycolysis basal media, create stock solutions by dissolving glucose in 3 mL, oligomycin in 270 µL (100 µM), and 2-deoxyglucose in 3 mL. Create a working oligomycin solution of 10 µM.
      2. Mitochondrial: Using mitochondrial basal media, create stock solutions by dissolving oligomycin in 630 µL (100 µM), carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) in 720 µL (100 µM), and rotenone/antimycin A in 540 µL (50 µM). Create working solutions of oligomycin (0.5-2.5 µM), FCCP (0.125-2.0 µM), and rotenone/antimycin A (0.5 µM).
        NOTE: We have found that 1.5 µM oligomycin and 2.0 µM FCCP produce the best results.
    3. Load test compounds into ports using the following volumes: port A-20 µL, port B-22 µL, port C-25 µL, port D-27 µL. Optional: Load drug or compound of choice into port A, and test compounds into port B, C, and D to assess acute effects on glycolysis or mitochondrial respiration. If not using additional drug or compound, leave port D empty.
  4. Running the assay
    1. Open the software and select Mitochondrial Stress Test.
      NOTE: This program can be used for glycolysis stress test as well, as extracellular acidification rate (ECAR) is measured.
    2. Select the wells that will be used. To subtract the background, ensure that at least 1 well has no cells.
    3. Run the program. Load the flux plate with the lid removed so that the plate is calibrated (~20 min).
    4. After the plate is calibrated, the software will give a prompt to load the cell plate. Take the cell plate out of the incubator, remove the bottom of the flux plate, and place the cell plate in the holder. Press run. The assay will take ~2.5 h to complete.
    5. Analyze the results using metabolic flux software7 or other analytical software of choice.

Results

Typical cell numbers obtained from the different tissues depend on the size, age, and sex of the animal. For an adult male mouse (i.e., 16 weeks old, ~30 g), the spleen may yield 3.0-4.0 × 106 macrophages, while the bone marrow (two tibias and two femurs) typically yields 1.0-1.5 × 106 monocytes (Figure 2A). The infarcted heart typically yields high numbers as well, depending on the day post MI4,5...

Discussion

Our method details the rapid extraction of macrophages from bone marrow, spleen, and the infarcted heart, which can then be used to perform downstream analyses such as extracellular metabolic flux analysis. The combination of these two methods is a powerful tool that can quantify metabolic changes in macrophages under different disease or injury states, or metabolic states such as exercise. While our method focused on bone marrow and splenic macrophages, other macrophage reservoirs can be used, such as the peritoneal com...

Disclosures

The authors have no conflicts of interest to declare.

Acknowledgements

We would like to acknowledge the funding that supported this work: NIH/NHBLI 166737, NIH R00 HL146888, NIH U54HL169191, NIH/NIGMS P20GM104357, and NIH/NIGMS P30GM149404 for this work.

Materials

NameCompanyCatalog NumberComments
Anti-CD11b Microbeads UltraPure, mouseMiltenyi Biotec130-126-725
Anti-Ly6G Microbeads UltraPure, mouseMiltenyi Biotec130-120-337
Collagenase type IIWorthingtonNC9522060
Dnase type IMillPore Sigma11284932001
GentleMACS Octo DissociatorMiltenyi Biotec130-096-427
GentleMACS C TubesMiltenyi Biotec130-093-237MACS cell dissociation tubes 
Hank balanced salt solutionFisher Scientific14-025-076
LS Magnetic ColumnsMiltenyi Biotec130-042-401
MACS MultiStandMiltenyi Biotec130-042-303
MS Magnetic Columns Miltenyi Biotec130-042-201
Monocyte Isolation Kit Bone Marrow, mouseMiltenyi Biotec130-100-629includes 1 mL of monocyte biotin-antibody cocktail, 2 mL of anti-biotin microbeads, 1 mL of FcR blocking reagent
OctoMACS SeparatorMiltenyi Biotec130-042-108
Pre-separation filters (30 µm)Miltenyi Biotec130-041-407
QuadroMACS SeparatorMiltenyi Biotec130-091-051
Red Blood Cell Lysis Solution (10x)Miltenyi Biotec130-094-183
Seahorse XFe96 AnalyzerAgilent
Seahorse XFe96 FluxPakAgilent103792-10018 Pro sensor cartridges, 18 Pro Cell Cutlure Microplates, 1 bottle of Seahorse XF Calibrant Solution
Seahorse XF Glycolysis Stress Test KitAgilent103020-1006 single-use pouches, each with glucose, oligomycin, and 2-deoxy-D-glucose
Seahorse XF Mitochondrial Stress Test KitAgilent103015-1006 single-use pouches, each with oligomycin, FCCP, and rotenone/antimycin A
Seahorse XF RPMI Medium, pH 7.4, 500 mLAgilent103576-100no phenol red, bicarbonate, glucose, pyruvate, or glutamine

References

  1. Ma, Y., Mouton, A. J., Lindsey, M. L. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl Res. 191, 15-28 (2018).
  2. Mouton, A. J., Li, X., Hall, M. E., Hall, J. E. Obesity, hypertension, and cardiac dysfunction: Novel roles of immunometabolism in macrophage activation and inflammation. Circ Res. 126 (6), 789-806 (2020).
  3. Mouton, A. J., et al. Dimethyl fumarate preserves left ventricular infarct integrity following myocardial infarction via modulation of cardiac macrophage and fibroblast oxidative metabolism. J Mol Cell Cardiol. 158, 38-48 (2021).
  4. Mouton, A. J., et al. Temporal changes in glucose metabolism reflect polarization in resident and monocyte-derived macrophages after myocardial infarction. Front Cardiovasc Med. 10, 1136252 (2023).
  5. Mouton, A. J., et al. Glutamine metabolism improves left ventricular function but not macrophage-mediated inflammation following myocardial infarction. Am J Physiol Cell Physiol. 327 (3), C571-C586 (2024).
  6. Mouton, A. J., et al. Mapping macrophage polarization over the myocardial infarction time continuum. Basic Res Cardiol. 113 (4), 26 (2018).
  7. . XF software. Agilent Seahorse Analytics Available from: https://www.agilent.com/en/product/cell-analysis/real-time-cell-metabolic-analysis/xf-software/agilent-seahorse-analytics-787485 (2025)
  8. Matsuura, Y., et al. Diabetes suppresses glucose uptake and glycolysis in macrophages. Circ Res. 130 (5), 779-781 (2022).
  9. Alexander, R. K., et al. Bmal1 integrates mitochondrial metabolism and macrophage activation. Elife. 9, e54090 (2020).
  10. Wan, Y., et al. miR-34a regulates macrophage-associated inflammation and angiogenesis in alcohol-induced liver injury. Hepatol Commun. 7 (4), e0089 (2023).
  11. Nomura, M., et al. Fatty acid oxidation in macrophage polarization. Nat Immunol. 17 (3), 216-217 (2016).
  12. Li, X., et al. Glycolytic reprogramming in macrophages and MSCs during inflammation. Front Immunol. 14, 1199751 (2023).
  13. Desousa, B. R., et al. Calculation of ATP production rates using the Seahorse XF Analyzer. EMBO Rep. 24 (10), e56380 (2023).
  14. Lewis, A. J. M., et al. Noninvasive immunometabolic cardiac inflammation imaging using hyperpolarized magnetic resonance. Circ Res. 122 (8), 1084-1093 (2018).
  15. Walls, J., Romero, M. Assessing T cell bioenergetic poise and spare respiratory capacity using extracellular flux analysis. Agilent Technologies application note. , 5994-4494 (2022).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved